Nasdaq Tern News Today

HC Wainwright reissued their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $5.50 price target on the stock. A number of other research analysts have also commented on TERN. JMP Securities decreased their price target on […]

HC Wainwright reaffirmed their neutral rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $5.50 target price on the stock. Several other research firms have also issued reports on TERN. JMP Securities lowered their price target on Terns Pharmaceuticals from $17.00 to […]

JMP Securities reiterated their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research note released on Tuesday morning, Benzinga reports. JMP Securities currently has a $15.00 target price on the stock. Other analysts also recently issued research reports about the stock. BMO Capital Markets increased their target price on […]

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have been given an average rating of “Moderate Buy” by the eight analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month […]

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The […]

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The […]

Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) and Sernova (OTCMKTS:SEOVF – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability. Profitability This table compares Terns Pharmaceuticals and Sernova’s […]

Suvretta Capital Management LLC increased its holdings in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 61.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,561,835 shares of the company’s stock after purchasing an additional 2,113,560 shares during the period. Terns Pharmaceuticals makes up approximately […]

JMP Securities reissued their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $17.00 price objective on the stock. Several other research analysts have also recently issued reports on TERN. HC Wainwright decreased their price objective on […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 […]